Life After Covid 19 Vaccination: Role of Spike Protein in Myocarditis/Blood Clotting

Life After Covid 19 Vaccination: Role of Spike Protein in Myocarditis/Blood Clotting

There have been so many reports regarding the covid 19 vaccines that the world doesn’t know what to believe anymore. Bottom line, we should all remember that a healthy life and less stress will always promote health, both physically and mentally speaking.

Recent reports have shed light on the contents of the LNP capsules, which contain mRNA and its encoded spike protein. It has been found that the spike protein and its subunit proteins may trigger an inflammatory response leading to serious adverse events such as myocarditis and blood clotting.

Former director of the CDC addresses the issues

Former director of the U.S. Centers for Disease Control and Prevention (CDC), Rochelle Walensky, had stated on “Good Morning America” in June 2021 that myocarditis cases were rare and usually resolved with rest and standard medications. However, this was based on a preliminary review of 300 cases and before conducting long-term follow-up.

A study published on Aug. 1 followed 40 adolescents in Hong Kong for up to a year. Follow-up testing performed in 26 patients with initial abnormal findings revealed that 58 percent of those with vaccine-associated myocarditis had persistent heart muscle scarring.

The study authors concluded that further research is necessary to better understand the long-term effects of myocarditis.

“There exists a potential long-term effect on exercise capacity and cardiac functional reserve during stress.”

This series demonstrates how exposure to the spike protein results in downstream cardiovascular issues.

Given that vaccination causes the body to produce more spike protein, it is clear that additional research was needed to understand the health impacts of vaccination prior to licensure.

Research has confirmed the detrimental effects of the spike protein and S1 subunit of SARS-CoV-2 on the cardiovascular system, including an increased risk of blood clotting. Moreover, post-vaccination, vaccine-induced spike proteins and S1 subunits have been detected in the bloodstream.

Laboratory studies have revealed that the spike protein can activate white blood cells, potentially causing inflammation or clotting. In young adults and adolescents who have experienced post-mRNA vaccine myocarditis, free spike protein has been found in their blood, while healthy control subjects without myocarditis showed no evidence of this protein.

The S1 subunit may interact with ACE2, platelets, and fibrin, leading to severe side effects such as inflammation, clots, myocarditis, and neurological problems.
It is believed that lipid nanoparticles (LNPs) have an adjuvant effect on the immune system, which reaches its peak within six hours of vaccination and returns to normal by day nine.

However, this timeline coincides with the onset of myocarditis, typically occurring within the first seven days following mRNA COVID-19 vaccination. It remains unclear how vaccination affects individuals who have previously contracted SARS-CoV-2, as no studies have been conducted to evaluate this.

Given the role of the spike protein in small vessel microclots during COVID-19 illness, cardiovascular effects post-vaccination should have been expected. The deadline for FDA-mandated post-authorization safety studies has passed, yet the full report has not been made available to the public to the best of our knowledge.

The spike protein and its effects

The spike protein is made up of two parts, the S1 and S2 subunits. The S1 subunit is located at the tip of the spike protein and plays a crucial role in attaching to the ACE2 receptor. Once the spike protein is attached to the receptor, it changes its shape to allow the virus to enter the host cell.

After entering the cell, the SARS-CoV-2 virus utilizes the cell’s protein manufacturing process to create new viral proteins.

Vaccines are designed to induce a strong immune response by selecting recognizable antigens. The mRNA COVID-19 vaccine was developed using the spike protein because it is responsible for attaching to cells and gaining entry.

However, recent research suggests that the spike protein and its S1 subunit may also be linked to cardiovascular complications that can occur after infection or vaccination.

Recent studies have revealed that the S2 subunit could hinder tumor suppression, which is why cancer patients may suffer more severe effects from COVID-19.

Additionally, research has demonstrated that the spike protein is present in the bloodstream after both COVID-19 infection and vaccination.

This protein could potentially alter the blood clotting process and trigger an excessive immune response. Gaining more insight into the functions of the spike protein and its S1 subunit will aid in identifying those who are most susceptible to severe illness or vaccine side effects.

You should check out more details about the cardiovascular effects of the spike protein, as well as the blood-clotting ones and more.

Rada Mateescu

Passionate about freedom, truth, humanity, and subjects from the science and health-related areas, Rada has been blogging for about ten years, and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.